Beijing Beilu Pharmaceutical Co (SZSE:300016) Net Income (Continuing Operations) : ¥-73.0 Mil (TTM As of Jun. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Beijing Beilu Pharmaceutical Co Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Beijing Beilu Pharmaceutical Co's Net Income (Continuing Operations) for the three months ended in Jun. 2024 was ¥3.6 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jun. 2024 was ¥-73.0 Mil.

Beijing Beilu Pharmaceutical Co Net Income (Continuing Operations) Historical Data

The historical data trend for Beijing Beilu Pharmaceutical Co's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Beilu Pharmaceutical Co Net Income (Continuing Operations) Chart

Beijing Beilu Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income (Continuing Operations)

Get a 7-Day Free Trial

342.44

154.00

110.29

-4.55

-83.20

Beijing Beilu Pharmaceutical Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Net Income (Continuing Operations)	Get a 7-Day Free Trial															-5.23	-9.17	-78.99	11.62	3.58

Beijing Beilu Pharmaceutical Co Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-73.0 Mil.

Beijing Beilu Pharmaceutical Co (SZSE:300016) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Beijing Beilu Pharmaceutical Co Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Beijing Beilu Pharmaceutical Co's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Beilu Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Beilu Pharmaceutical Co Ltd (SZSE:300016) » Definitions » Net Income (Continuing Operations)

Traded in Other Exchanges

N/A

Address

No. 3, Shuiyuan West Road, Miyun District, Beijing, CHN, 100082

Website

http://www.beilu.com.cn

Beijing Beilu Pharmaceutical Co Ltd is engaged in the research and development, production, and sales of pharmaceutical products. The products of the company are contrasted agent series, psychotropic, and hypoglycemic products which include iopamidol injection, iodixanol injection, and reglinide tablets.

Executives

Zong Li	Directors, executives
Hong Cheng Jie	Director
Duan Xian Zhu	Directors, executives
Zhu Zhi	Director
Wang Dai Xue	Director
Li Hong	Directors, executives
Liu Ning	Directors, executives
Wu Rui Hua	Directors, executives
Wu Jie	Executives
Liu Dong Long	Supervisors
Hong Wei	Directors, executives

Beijing Beilu Pharmaceutical Co Headlines

No Headlines